6618 Stock Overview
An investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6618 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
JD Health International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$28.20 |
| 52 Week High | HK$40.00 |
| 52 Week Low | HK$19.48 |
| Beta | 0.99 |
| 1 Month Change | -0.53% |
| 3 Month Change | -19.43% |
| 1 Year Change | -27.88% |
| 3 Year Change | -52.08% |
| 5 Year Change | n/a |
| Change since IPO | -74.36% |
Recent News & Updates
JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17
Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Recent updates
JD Health International's (HKG:6618) Returns On Capital Not Reflecting Well On The Business
Dec 17Investors Appear Satisfied With JD Health International Inc.'s (HKG:6618) Prospects
Nov 04Is Now An Opportune Moment To Examine JD Health International Inc. (HKG:6618)?
Sep 26A Look At The Fair Value Of JD Health International Inc. (HKG:6618)
Sep 05Results: JD Health International Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 19The Returns On Capital At JD Health International (HKG:6618) Don't Inspire Confidence
Aug 08Why We're Not Concerned About JD Health International Inc.'s (HKG:6618) Share Price
Jul 21This Is Why JD Health International Inc.'s (HKG:6618) CEO Compensation Looks Appropriate
Jun 14Calculating The Intrinsic Value Of JD Health International Inc. (HKG:6618)
May 21JD Health International Inc.'s (HKG:6618) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Apr 17JD Health International (HKG:6618) Is Reinvesting At Lower Rates Of Return
Apr 08At HK$29.80, Is It Time To Put JD Health International Inc. (HKG:6618) On Your Watch List?
Mar 01Revenues Tell The Story For JD Health International Inc. (HKG:6618)
Jan 16Shareholder Returns
| 6618 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | -3.8% | 1.4% | 2.1% |
| 1Y | -27.9% | -29.5% | 17.6% |
Return vs Industry: 6618 exceeded the Hong Kong Consumer Retailing industry which returned -29.5% over the past year.
Return vs Market: 6618 underperformed the Hong Kong Market which returned 17.6% over the past year.
Price Volatility
| 6618 volatility | |
|---|---|
| 6618 Average Weekly Movement | 8.5% |
| Consumer Retailing Industry Average Movement | 8.8% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 3.9% |
Stable Share Price: 6618 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 6618's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 3,177 | Enlin Jin | ir.jdhealth.com |
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services.
JD Health International Inc. Fundamentals Summary
| 6618 fundamental statistics | |
|---|---|
| Market cap | HK$91.80b |
| Earnings (TTM) | HK$2.78b |
| Revenue (TTM) | HK$58.25b |
32.4x
P/E Ratio1.5x
P/S RatioIs 6618 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6618 income statement (TTM) | |
|---|---|
| Revenue | CN¥54.76b |
| Cost of Revenue | CN¥42.40b |
| Gross Profit | CN¥12.36b |
| Other Expenses | CN¥9.74b |
| Earnings | CN¥2.62b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 22.57% |
| Net Profit Margin | 4.78% |
| Debt/Equity Ratio | 0% |
How did 6618 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 13:39 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JD Health International Inc. is covered by 32 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yiqun Chen | BOCI Research Ltd. |
| Xiaomeng Zhuang | BofA Global Research |
| Shun Kei Law | CCB International Securities Limited |